The Role of Graphene Oxide in the Inhibition of Migration and Invasion of Cancer Cells by Destroying Actin Cytoskeleton and via Inhibiting the Activities of ETC Complexes

Abstract

Abstract: Cancer is one of the most important threats to public health. Cancer is characterized by cell proliferation that has eluded central endogenous control mechanisms. Cervical cancer is the third most common cancer among women, followed by skin cancer and breast cancer, the first and second most common causes, respectively. In developing countries, cervical cancer is usually the most common cancer in women and may account for 25% of all female cancers. Over the years, the diagnosis and treatment of cervical cancer have made rapid progress, resulting in a decline in the mortality and morbidity of the disease. Unfortunately, although surgery and radiotherapy have effective treatment options for early cervical cancer, poor prognosis is still a challenge in the treatment of metastatic cervical cancer. Therefore, it is very important to reveal the mechanism of cervical cancer and explore new therapies against tumor invasiveness. At present, it is reported that nanomaterials are used in the detection and treatment of various types of malignant tumors due to their different targeting effects in many fields, such as imaging, immune detection, chemotherapy, radiotherapy and immunotherapy. The cytotoxicity and inhibitory effects of graphene oxide (GO) on tumor invasion and metastasis were studied in recent studies using the human cervical cancer Hela cell line, as well as the probable mechanisms and signaling pathways involved. Here we collect the last reports, with focus on the role of GO in the inhibition of migration and invasion of cancer cells with the goal of exposing possible potential pathways to provide new insights for specific treatment of cancer.